In addition, the strong involvement of the PDGFA/PDGFRα axis in promoting the epithelial–mesenchymal transition (EMT) of HCC, as confirmed by several in vivo studies [121,122,123,124], further supports the correlation between its altered signaling and tumor metastatic capacity. The gene discussed is PDGFRA; the disease is hepatocellular carcinoma.